Adolescent and Young Adult Cancer Survivors Report Cognitive, Sexual Late Effects

Adolescent and Young Adult Cancer Survivors Report Cognitive, Sexual Late Effects
Adolescent and Young Adult Cancer Survivors Report Cognitive, Sexual Late Effects

CHICAGO, IL— Adult and young adult (AYA) cancer survivors face cognitive and sexual late effects from cancer and its treatment, according to data compiled from an online cancer survivorship care planning tool presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting.

AYA cancer survivors “report significant late effects, including perceived cognitive changes and prominent sexual side effects, and these may warrant specific counseling and support,” reported lead study author James Metz, MD, of the Hospital of the University of Pennsylvania in Philadelphia, and coauthors.

Data were acquired from the www.livestrongcareplan.com Web site cancer survivor care planning tool, which includes questions about late effects of cancer and anticancer treatment.

AYA respondents, who represented 32% of all survivors using the tool, reported time since cancer diagnosis ranging from less than 1 year to 15 years (median, 2.1 years). The median age of AYA survivors was 30 years (18-35 years).

The most common diagnoses among AYA survivors had been hematologic, breast, and genitourinary cancers.

More than half (54%) reported cognitive changes, and many reported sexual side effects, including erectile dysfunction (7% of males) and vaginal dryness and shrinkage (47% of females).

 “AYA survivors are prominent users of this tool, although their diagnosis profile differs from that of older users,” Dr. Metz noted.

Abstract #9605

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs